Advertisement
Research Article

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

  • Hanyin Cheng equal contributor,

    equal contributor Contributed equally to this work with: Hanyin Cheng, Lina Zhang

    Affiliation: Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Lina Zhang equal contributor,

    equal contributor Contributed equally to this work with: Hanyin Cheng, Lina Zhang

    Affiliation: Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    X
  • David E. Cogdell,

    Affiliation: Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Hong Zheng,

    Affiliation: Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    X
  • Aaron J. Schetter,

    Affiliation: Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Matti Nykter,

    Affiliation: Department of Signal Processing, Tampere University of Technology, Tampere, Finland

    X
  • Curtis C. Harris,

    Affiliation: Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

    X
  • Kexin Chen mail,

    wzhang@mdanderson.org (WZ); shamilto@mdanderson.org (SRH); chenkexin1963@yahoo.com (KC)

    Affiliation: Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    X
  • Stanley R. Hamilton mail,

    wzhang@mdanderson.org (WZ); shamilto@mdanderson.org (SRH); chenkexin1963@yahoo.com (KC)

    Affiliation: Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Wei Zhang mail

    wzhang@mdanderson.org (WZ); shamilto@mdanderson.org (SRH); chenkexin1963@yahoo.com (KC)

    Affiliation: Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Published: March 17, 2011
  • DOI: 10.1371/journal.pone.0017745

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.